2017
DOI: 10.1167/iovs.16-21405
|View full text |Cite
|
Sign up to set email alerts
|

Myopia and Late-Onset Progressive Cone Dystrophy Associate to LVAVA/MVAVA Exon 3 Interchange Haplotypes of Opsin Genes on Chromosome X

Abstract: Here, we show that LVAVA haplotype of the OPN1LW gene and MVAVA haplotype of the OPN1MW gene cause apparently nonsyndromic high myopia in young patients but lead to progressive cone-rod dystrophy with deuteranopia and protanopia in middle-aged patients corresponding to a previously unknown disease course. To the best of our knowledge, this is the first report on the joint effect of these toxic haplotypes in the two opsin genes on chromosome X.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
20
2

Year Published

2018
2018
2021
2021

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 23 publications
(22 citation statements)
references
References 40 publications
0
20
2
Order By: Relevance
“…It is well known that high-grade myopia is associated with rare interchange exon 3 haplotypes, such as LVAV A and LIAVA, of the L or M opsin genes ( Carroll et al, 2012 ; Greenwald et al, 2017 ; McClements et al, 2013 ; Orosz et al, 2017 ) (none in our sample; Table 3 ), resulting in incorrect splicing of exon 3 and greatly reduced amount of functional opsin in the cones harbouring the mutation. Eye growth associated with rare interchange haplotypes is suggested to be caused by erroneous contrast signals produced by mosaics with both normal cones and cones with mutant opsins ( Greenwald et al, 2017 ; Patterson et al, 2018 ).…”
Section: Discussionmentioning
confidence: 90%
See 1 more Smart Citation
“…It is well known that high-grade myopia is associated with rare interchange exon 3 haplotypes, such as LVAV A and LIAVA, of the L or M opsin genes ( Carroll et al, 2012 ; Greenwald et al, 2017 ; McClements et al, 2013 ; Orosz et al, 2017 ) (none in our sample; Table 3 ), resulting in incorrect splicing of exon 3 and greatly reduced amount of functional opsin in the cones harbouring the mutation. Eye growth associated with rare interchange haplotypes is suggested to be caused by erroneous contrast signals produced by mosaics with both normal cones and cones with mutant opsins ( Greenwald et al, 2017 ; Patterson et al, 2018 ).…”
Section: Discussionmentioning
confidence: 90%
“…There is evidence for this in the fact that there is a lower prevalence of myopia in red-green colour vision deficient students, who have highly skewed L:M cone ratios as a consequence of lacking L or M cones ( Ostadimoghaddam et al, 2014 ; Qian et al, 2009 ). Further evidence is the association between myopia and rare interchange haplotypes in exon 3 of the L and M cone opsin genes at chromosome location Xq28 (designated OPN1LW and OPN1MW, respectively) ( Carroll et al, 2012 ; Greenwald, Kuchenbecker, Rowlan, Neitz, & Neitz, 2017 ; McClements et al, 2013 ; Orosz et al, 2017 ). The highly variable nucleotide sequences in humans control the spectral tuning of the opsin and affect other aspects of protein structure and function, such as proper splicing of exon 3 in the precursor messenger RNA (pre-mRNA) ( Greenwald et al, 2017 ).…”
Section: Introductionmentioning
confidence: 99%
“…The molecular complexity of the L-and M-cone opsin genes (OPN1LW and OPN1MW) has been explored not only to understand the basis of color vision but also to elucidate the molecular genetic causes of X-linked cone diseases. 1,3,6,9,10,11,[26][27][28][29] BCM causes decreased L/M-cone vision due to simultaneous OPN1LW and OPN1MW gene defects as a result of one of multiple mutation mechanisms, such as large deletions involving upstream regulatory sequences (i.e., locus control region and promoters) and/or parts of or the entire OPN1LW and OPN1MW genes, missense mutations or nonsense mutations, and L/M interchange mutations. 7,9,26,[30][31][32] Among the more common genotypes reported are large deletions and the C203R missense mutation.…”
Section: Discussionmentioning
confidence: 99%
“…Clinical exome sequencing was performed as described previously [36]. More than 95% of the target sequence was covered at least 20-fold.…”
Section: Clinical Exome Sequencingmentioning
confidence: 99%